Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-7-16
pubmed:abstractText
Although the beta(3)-adrenoceptor (AR) has been suggested to be involved in regulation of gut motility and visceral algesia, the precise mechanisms have been unknown. beta(3)-AR has been postulated to have a nonneuronal expression, being initially characterized in adipocytes and subsequently in the smooth muscle. We aimed to investigate the expression of beta(3)-AR in human enteric nervous system and its role in motility and visceral algesia.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0016-5085
pubmed:author
pubmed:issnType
Print
pubmed:volume
133
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
175-83
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:17631141-Abdominal Pain, pubmed-meshheading:17631141-Adrenergic beta-3 Receptor Agonists, pubmed-meshheading:17631141-Adrenergic beta-Agonists, pubmed-meshheading:17631141-Animals, pubmed-meshheading:17631141-Castor Oil, pubmed-meshheading:17631141-Cathartics, pubmed-meshheading:17631141-Colon, pubmed-meshheading:17631141-Diarrhea, pubmed-meshheading:17631141-Dioxoles, pubmed-meshheading:17631141-Gastrointestinal Motility, pubmed-meshheading:17631141-Humans, pubmed-meshheading:17631141-Immunohistochemistry, pubmed-meshheading:17631141-Mustard Plant, pubmed-meshheading:17631141-Myenteric Plexus, pubmed-meshheading:17631141-Plant Oils, pubmed-meshheading:17631141-Rats, pubmed-meshheading:17631141-Rats, Inbred Strains, pubmed-meshheading:17631141-Receptors, Adrenergic, beta-3, pubmed-meshheading:17631141-Somatostatin, pubmed-meshheading:17631141-Submucous Plexus, pubmed-meshheading:17631141-Visceral Afferents
pubmed:year
2007
pubmed:articleTitle
Demonstration of functional neuronal beta3-adrenoceptors within the enteric nervous system.
pubmed:affiliation
Neurology and Gastrointestinal Centre of Excellence in Drug Discovery, GlaxoSmithKline, Harlow, United Kingdom. Selim.2.Cellek@gsk.com <Selim.2.Cellek@gsk.com>
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't